1. O-007ZEBRA: an ACCRU/IRCI multicenter phase 2 study of pembrolizumab in patients with advanced small bowel adenocarcinoma (SBA). (2nd July 2019) Authors: Pedersen, K; Foster, N; Overman, M; Boland, P; Kim, S; Arrambide, K; Jaszewski, B; Welch, J; Wilson, R; McWilliams, R Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗